Learn
BLIS K12 and M18: The Strains, and What the Trials Show
BLIS K12 and M18 are two strains of the same mouth bacterium, studied for different jobs. Here's what the real trials show, negative results included.
If you shop for oral probiotics, two names keep coming up: BLIS K12 and BLIS M18. Both are strains of the same friendly mouth bacterium, Streptococcus salivarius, and “BLIS” refers to the natural antibacterial compounds they make. But they’ve been studied for different things, and lumping them together is the first mistake most product pages make.
On this page
About the K12 and M18 strains
S. salivarius is one of the first bacteria to colonize a healthy mouth, so using it as a probiotic is an attempt to reinforce a natural resident rather than introduce a stranger. K12 is the strain with the most breath and throat research. M18 is a different strain aimed more at plaque and gum inflammation. Same species, different jobs, different evidence. Don’t let a product use K12’s data to sell you M18.
About this graphic
The infographic compares two Streptococcus salivarius strains. K12 is studied more for breath and throat outcomes, with mixed halitosis results and hygiene still first. M18 is studied more for plaque and gingivitis, with smaller, mixed evidence that may fade after stopping. Evidence must not be transferred between the strains or to an uncoded species label.
K12 for breath: what the RCTs show
This is K12’s strongest area, and even here it’s mixed. A 2025 review of six randomized trials found most of them reduced volatile sulfur compounds, the gases behind mouth odor (PMID 40951721). Encouraging.
Now the finding that changes how you use it. A K12 trial conducted without tongue pretreatment found no benefit versus placebo; the authors inferred that reducing tongue coating before supplementation may be necessary (PMID 32227309). The trial did not test a tongue-cleaning arm, so that explanation remains a hypothesis. K12 is an add-on to oral hygiene, not a replacement for it.
One more honesty note: an early, often-cited K12 study was run by authors affiliated with the strain’s manufacturer (PMID 16553730). That doesn’t make it wrong, but it’s a conflict of interest worth knowing, and it’s why the independent reviews matter more.
M18, where the evidence is thinner
M18 targets plaque and gingivitis, and the evidence is smaller and less consistent. A 4-week trial in adults with gingivitis found M18 improved the gum and plaque scores during use, but after a follow-up most of that gain had faded (PMID 37764667). A study in cavity-prone children reported a more favorable risk score (PMID 26491371). But a separate trial in orthodontic patients found M18 did not change plaque or gum inflammation at all, only breath gases (PMID 31022704). There’s no dedicated systematic review of M18 yet, which is itself worth saying.
Colonization is transient, so what does that mean for use?
Here’s the practical takeaway. These strains generally don’t take up permanent residence. In the M18 gingivitis trial, most of the measured gain faded after use stopped. Treat either strain as a use-dependent add-on rather than a one-time course, while recognizing that persistence and clinical effect can differ by strain, person and outcome.
Frequently asked questions
Is K12 or M18 better?
Neither, they’re for different things. K12 has the better breath case; M18 is aimed at plaque and gums with thinner, mixed evidence. Match the strain to your goal.
Does K12 cure bad breath?
No. Some trials report lower odor gases, while a K12 trial without tongue pretreatment did not beat placebo (PMID 40951721; PMID 32227309). Long-term persistence after stopping has not been established for this breath outcome. See the bad breath supplement guide.
Do I have to keep taking it?
Probably, if you want to maintain any use-dependent effect. Colonization is often temporary, but long-term persistence and benefit have not been established equally for K12 and M18.
How do I know a product really contains these strains?
The label has to name “BLIS K12” or “BLIS M18” specifically. A generic “S. salivarius” without the strain code can’t be tied to this research. Compare products in the oral probiotics guide.
K12 and M18 are not interchangeable
K12 is usually discussed for throat ecology and breath-related outcomes. M18 is marketed more toward plaque and acid balance. The strain code matters because the data for one cannot be assigned to every Streptococcus salivarius product or silently transferred to the other strain.
Check the route as well. A slow-dissolve lozenge after brushing keeps the organism in the mouth longer than a capsule swallowed with water. Even then, colonization is often temporary. Continued use may be needed to maintain any effect, which changes the real monthly cost.
A fair way to evaluate one
Choose a product that prints the strain code and dose, keep the rest of your routine stable and judge one narrow outcome. Freshness or recurrence of a familiar throat pattern is easier to assess than a vague promise to “reset” the microbiome. Persistent halitosis, frequent infections or gum symptoms still need the underlying cause evaluated. NHS guidance advises seeing a dentist when bad breath does not clear after several weeks of self-care or occurs with painful, bleeding or swollen gums, toothache or loose adult teeth (NHS, reviewed June 2025).
References
- National Health Service (NHS). Bad breath [Internet]. Last reviewed June 5, 2025; accessed July 17, 2026. Available from: NHS — Bad breath
- Passadakis G, Neophytou C, Davidopoulou S, Papadimitriou K. Effectiveness of Probiotics in Managing Oral Halitosis: A Systematic Review of Randomized Controlled Trials. J Int Soc Prev Community Dent. 2025 Jul-Aug;15(4):301-312. https://doi.org/10.4103/jispcd.jispcd_19_25 · PubMed PMID 40951721
- He L, Yang H, Chen Z, Ouyang X. The Effect of Streptococcus salivarius K12 on Halitosis: a Double-Blind, Randomized, Placebo-Controlled Trial. Probiotics Antimicrob Proteins. 2020 Dec;12(4):1321-1329. https://doi.org/10.1007/s12602-020-09646-7 · PubMed PMID 32227309
- Burton JP, Chilcott CN, Moore CJ, Speiser G, Tagg JR. A preliminary study of the effect of probiotic Streptococcus salivarius K12 on oral malodour parameters. J Appl Microbiol. 2006 Apr;100(4):754-64. https://doi.org/10.1111/j.1365-2672.2006.02837.x · PubMed PMID 16553730
- Babina K, Salikhova D, Doroshina V, Makeeva I, Zaytsev A, Uvarichev M, et al. Antigingivitis and Antiplaque Effects of Oral Probiotic Containing the Streptococcus salivarius M18 Strain: A Randomized Clinical Trial. Nutrients. 2023 Sep 6;15(18). https://doi.org/10.3390/nu15183882 · PubMed PMID 37764667
- Benic GZ, Farella M, Morgan XC, Viswam J, Heng NC, Cannon RD, et al. Oral probiotics reduce halitosis in patients wearing orthodontic braces: a randomized, triple-blind, placebo-controlled trial. J Breath Res. 2019 May 31;13(3):036010. https://doi.org/10.1088/1752-7163/ab1c81 · PubMed PMID 31022704
- Di Pierro F, Zanvit A, Nobili P, Risso P, Fornaini C. Cariogram outcome after 90 days of oral treatment with Streptococcus salivarius M18 in children at high risk for dental caries: results of a randomized, controlled study. Clin Cosmet Investig Dent. 2015;7:107-13. https://doi.org/10.2147/CCIDE.S93066 · PubMed PMID 26491371
Who's behind this